International Journal of Mycobacteriology (Jan 2014)

Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges

  • Brittany J Holmes,
  • Richard W LaRue,
  • James H Black III,
  • Kim Dionne,
  • Nicole M Parrish,
  • Michael T Melia

DOI
https://doi.org/10.1016/j.ijmyco.2013.11.002
Journal volume & issue
Vol. 3, no. 1
pp. 60 – 65

Abstract

Read online

A live, attenuated form of Mycobacterium bovis, bacillus Calmette–Guérin (BCG), is commonly used as intravesical immunotherapy for non-invasive urothelial bladder carcinoma. While complications are rare, dissemination can occur. A case of mycotic aortic aneurysm following BCG administration with recovery of Mycobacterium bovis in culture is reported. A review of the published experience with this problem is also presented.

Keywords